nocodazole has been researched along with bisindolylmaleimide i in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dransfield, I; McMeekin, SR; Ruchaud-Sparagano, MH; Walker, TR | 1 |
| Hahn, TR; Hong, JW; Lee, MS; Lim, IK; Moon, E; Ryu, MS | 1 |
2 other study(ies) available for nocodazole and bisindolylmaleimide i
| Article | Year |
|---|---|
A critical 'threshold' of beta 2-integrin engagement regulates augmentation of cytokine-mediated superoxide anion release.
Topics: Binding Sites; CD18 Antigens; Cell Adhesion; Cytochalasin D; Cytokines; Cytoskeleton; Genistein; Humans; Imidazoles; Indoles; Integrin beta Chains; Magnesium; Maleimides; Microspheres; Mitogen-Activated Protein Kinases; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Nocodazole; Particle Size; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Pyridines; Pyrimidines; Serum Albumin; src-Family Kinases; Superoxides; Technology, Pharmaceutical; Tissue Adhesions; Tumor Necrosis Factor-alpha | 2004 |
TIS21/BTG2/PC3 is expressed through PKC-delta pathway and inhibits binding of cyclin B1-Cdc2 and its activity, independent of p53 expression.
Topics: Animals; Carbazoles; Caspase 3; Caspases; CDC2 Protein Kinase; Cell Cycle; Cell Death; Cyclin A; Cyclin B; Cyclin B1; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; G2 Phase; Genes, Tumor Suppressor; Humans; Immediate-Early Proteins; Indoles; Maleimides; Mice; NIH 3T3 Cells; Nocodazole; Protein Binding; Protein Kinase C; Protein Kinase C-delta; Pyridines; Retinoblastoma Protein; RNA, Messenger; Signal Transduction; Tumor Suppressor Protein p53; Tumor Suppressor Proteins; U937 Cells | 2004 |